• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quintiles Will Not Pursue ClinPhone Acquisition, Parexel’s Offer Stands

Quintiles Will Not Pursue ClinPhone Acquisition, Parexel’s Offer Stands

July 2, 2008
CenterWatch Staff

Durham, N.C.-based contract research organization (CRO) Quintiles stated it will not counter Waltham, Mass.-based rival CRO Parexel’s bid for the acquisition of ClinPhone, a clinical technology company based in the UK. Parexel’s offer is $182 million in cash, an 86% premium over ClinPhone's share price.

Shortly after Parexel’s bid on June 13, Quintiles released a statement announcing its intention to counter-bid for ClinPhone. At the time the company said: “Quintiles believes that the operations of ClinPhone are a strategic fit with Quintiles’ clinical research capabilities and confirms that it has been in discussions with the board of ClinPhone, which may or may not lead to an offer.”

North Carolina’s News and Observer reported Quintiles declined to comment on the specific reason for the company's reversal; however, it quoted Dick Jones, senior director corporate communications, as saying, "It was worth taking a look." The company plans to “focus on in-house technology” instead of looking for a similar deal in the future, it was reported.

This is not Parexel’s first attempt to buy the company. In February 2008, Parexel made an initial bid for ClinPhone. Although financial details were not disclosed, ClinPhone considered the offer too low.
Already a leading player in its sector, ClinPhone became much more than an interactive voice response and interactive web response (IVR/IWR) company in March 2008, when it launched a combination EDC product – gained through the acquisition of EDC firm Datalabs.

ClinPhone has about 730 employees. Parexel had 2007 revenues of more than $900 million and about 5,600 employees. ClinPhone would fit with within Parexel’s technology subsidiary Perceptive Informatics and would give it an electronic data capture (EDC) system.

Parexel had arranged a $300 million credit facility with JPMorgan Chase Bank and Keybank National Association. Parexel expects that the acquisition will be dilutive to earnings in its financial year ending June 30, 2009.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing